M42 is a global, AI-powered healthcare company headquartered in Abu Dhabi, established in 2022 through the merger of G42 Healthcare and Mubadala Health. With over 20,000 employees and more than 450 facilities across 26 countries, M42 integrates advanced technologies like artificial intelligence and genomics to deliver precise, preventive, and patient-centric care. The company operates several specialized platforms, including Global Patient Care, Digital Health Solutions, Integrated Health Solutions, and AI Life Sciences, aiming to transform healthcare delivery and outcomes worldwide. M42's initiatives, such as the Emirati Genome Programme and the Abu Dhabi Biobank, underscore its commitment to advancing medical research and personalized medicine.